The US TB vaccines specialist firm Aeras has appointed Dr Thomas Evans as its president and chief executive effective immediately.

Dr Evans, who joined Aeras as chief scientific officer in 2010, has been acting as interim president and chief scientific officer since early 2013.

Prior to joining Aeras, Dr Evans was VP and head of translational sciences, Asia, at Novartis Institutes for BioMedical Research in Shanghai, China.

He previously held positions as vice president of infectious diseases and clinical research at Vical Inc., and as Professor of medicine and chief of the infectious diseases division at the University of California, Davis.